Thom C. Fungi in cheese ripening; Camembert and Roquefort. // U.S.D.A. Bureau of Animal Industry Bulletin. 1906. Vol. 82, P. 1–39.
Vallone L., Giardini A., Soncini G. Secondary metabolites from Penicillium roqueforti, a starter for the production of gorgonzola cheese. // Ital J Food Saf. 2014. Vol. 3, № 3. P. 2118.; Larsen A.G., Knechel S. Antimicrobial activity of food-related Penicillium sp. against pathogenic bacteria in laboratory media and a cheese model system. // J Appl Microbiol. 1997. Vol. 83, № 1. P. 111–119.
Грин Н., Стаут У., Тейлор Д. Биология. 10 изд. в 3-х томах. – Издательство: Бином. Лаборатория знаний, 2018. – 1340 c.
Hymes K.B., Cheung T., Greene J.B., Prose N.S., Marcus A., Ballard H., William D.C., Laubenstein L.J. Kaposi’s sarcoma in homosexual men-a report of eight cases. // Lancet. 1981. Vol. 2, № 8247. P. 598–600; Centers for Disease Control (CDC). Kaposi’s sarcoma and Pneumocystis pneumonia among homosexual men – New York City and California. // MMWR Morb Mortal Wkly Rep. 1981. Vol. 30, № 25. P. 305–308.
Schloss P.D., Handelsman J. Status of the microbial census. // Microbiol Mol Biol Rev. 2004. Vol. 68, № 4. P. 686–691.
Sender R., Fuchs S., Milo R. Revised estimates for the number of human and bacteria cells in the body. // PLoS Biol. 2016. Vol.14, № 8. e1002533.
Galland L. The gut microbiome and the brain. // J Med Food. 2014. Vol.17, № 12. P. 1261–1272.
contras: Roberts E., Lowe I. P., Guth L., Jelinek B. (1958). Distribution of γ-aminobutyric acid and other amino acids in nervous tissue of various species. J. Exp. Zool. 138, 313–328; Kuriyama K., Sze P. Y. (1971). Blood – brain barrier to h3-γ-aminobutyric acid in normal and amino oxyacetic acid-treated animals. Neuropharmacology 10, 103–108; Van Gelder N. M., Elliott K. A. C. (1958). Disposition of γ-aminobutyric acid administered to mammals. J. Neurochem. 3, 139–143. Knudsen G. M., Poulsen H. E., Paulson O. B. (1988). Blood – brain barrier permeability in galactosamine-induced hepatic encephalopathy. J. Hepatol. 6, 187–192; pros: Takanaga H., Ohtsuki S., Hosoya K., Terasaki T. (2001). GAT2/BGT-1 as a system responsible for the transport of γ-aminobutyric acid at the Mouse Blood – Brain Barrier. J. Cereb. Blood Flow Metab. 21, 1232–1239; Kakee A., Takanaga H., Terasaki T., Naito M., Tsuruo T., Sugiyama Y. (2001). Efflux of a suppressive neurotransmitter, GABA, across the blood – brain barrier. J. Neurochem. 79, 110–118.
Boonstra E., Roy de Kleijn R., Colzato L.S., Alkemade A., Forstmann B.U., Nieuwenhuis S. Neurotransmitters as food supplements: the effects of GABA on brain and behavior. // Front Psychol. 2015. Vol. 6. Article 1520.
Грин Н., Стаут У., Тейлор Д. Биология. 10 изд. в 3-х томах. – Издательство: Бином. Лаборатория знаний, 2018. – 1340c.
Cardoso M.S., Reis-Cunha J.L., Bartholomeu D.C. Evasion of the immune response by Trypanosoma cruzi during acute infection // Front Immunol. 2015. Vol. 6, p.659.
Maizels R.M., McSorley H.J. Regulation of the host immune system by helminth parasites. // J Allergy Clin Immunol. 2016. Vol. 138, № 3. P. 666–675.
Mahanty S., Mollis S.N., Ravichandran M., Abrams J.S., Kumaraswami V., Jayaraman K., Ottesen E.A., Nutman T.B. High levels of spontaneous and parasite antigen-driven interleukin-10 production are associated with antigen-specific hyporesponsiveness in human lymphatic filariasis // J Infect Dis. 1996. Vol. 173, № 3. P. 769–773.
Грин Н., Стаут У., Тейлор Д. Биология. 10 изд. в 3-х томах. – Издательство: Бином. Лаборатория знаний, 2018. – 1340 c.
Smallwood T.B., Giacomin P.R., Loukas A., Mulvenna J.P., Clark R.J., Miles J.J. Helminth immunomodulation in autoimmune disease. // Front Immunol. 2017. Vol. 8. Article 453.
RosenblumM.D., RemediosK.A., AbbasA.K. Mechanismsofhumanautoimmunity. // JClinInvest. 2015. Vol.125, № 6. P. 2228–2233.
Tang D., Rui Kang R., Coyne C.B., Zeh H.J., Lotze M.T. PAMPs and DAMPs: Signal 0s that Spur Autophagy and Immunity. // Immunol Rev. 2012. Vol. 249, № 1. P. 158–175.
Candeias S.M., Gaipl U.S. The immune system in cancer prevention, development and therapy. // Anticancer Agents Med Chem. 2016. Vol.16, № 1. P. 101–107.
Oiseth S.J., Aziz M.S. Cancer immunotherapy: a brief review of the history, possibilities, and challenges ahead. // J Cancer Metastasis Treat 2017. Vol. 3. P. 250–261.
Leach D. R., Krummel M. F., Allison J. P. (1996). Enhancement of antitumor immunity by CTLA-4 blockade. // Science. 1996. Vol. 271, № 5256. P. 1734–1736; Iwai Y., Terawaki S., Honjo T. PD-1 blockade inhibits hematogenous spread of poorly immunogenic tumor cells by enhanced recruitment of effector T cells. // Int Immunol. 2005. Vol. 17, № 2. P. 133–144.
Li J., Li W., Huang K., Zhang Y., Kupfer G., Zhao Q. Chimeric antigen receptor T cell (CAR-T) immunotherapy for solid tumors: lessons learned and strategies for moving forward. // J Hematol Oncol. 2018. Vol. 11, № 1. Article 22; Saudemont A., Jespers L., Clay T. Current status of gene engineering cell therapeutics. // Front Immunol. 2018. Vol. 9. Article 153.
Fenner F., Henderson D.A., Arita I., Jezek Z., Ladnyi I.D. Smallpox and its Eradication. Geneva: World Health Organization, 1988. WHO Library Database.
Dinc G., Ulman Y.I. The introduction of variolation ‘A La Turca’ to the West by Lady Mary Montagu and Turkey’s contribution to this. // Vaccine. 2007. Vol. 25, P. 4261–4265.
Gross CP, Sepkowitz KA. The myth of the medical breakthrough: smallpox, vaccination, and Jenner reconsidered. IntJInfectDis 1998;3(1):54–60.
Dinc G., Ulman Y.I. The introduction of variolation ‘A La Turca’ to the West by Lady Mary Montagu and Turkey’s contribution to this. // Vaccine. 2007. Vol. 25, P. 4261–4265.
Микиртичан Г.Л. (2016). Из истории вакцинопрофилактики: оспопрививание. Российский педиатрический журнал. 2016. Том. 19, С. 55–62.
Stefan Riedel. (2005). Edward Jenner and the History of Smallpox and Vaccination. Baylor University Medical Center Proceedings. 18, 21–25.Pead PJ. Benjamin Jesty: new light in the dawn of vaccination. Lancet 2003; 362:2104–9.
http://www.who.int/archives/fonds_collections/bytitle/fonds_6/en/
https://www.bbc.com/news/uk-england-birmingham-45101091.
https://vaccine-safety-training.org/types-of-vaccine.html
http://www.who.int/ru/news-room/fact-sheets/detail/rabies.
http://www.who.int/features/qa/84/ru/.
http://www.who.int/immunization/global_vaccine_action_plan/ru/.
http://www.who.int/immunization/newsroom/thiomersal_information_sheet/ru/.
http://www.who.int/ru/news-room/fact-sheets/detail/human-papillomavirus-(hpv)-and-cervical-cancer.
http://www.who.int/wer/2009/wer8415/en/.
http://www.who.int/ru/news-room/fact-sheets/detail/hepatitis-b.
Baym M., Lieberman T.D., Kelsic E.D., Chait R., Gross R., Yelin I., Kishony R. Spatiotemporal microbial evolution on antibiotic landscapes. // Science. 2016. Vol. 353, № 6304. P. 1147–1151.
Pidot S.J., Gao W., Buultjens A.H., Monk I.R., Guerillot R., Carter G.P., Lee J.Y.H., Lam M.M.C., Grayson M.L., Ballard S.A., Mahony A.A., Grabsch E.A., Kotsanas D., Korman T.M., Coombs G.W., Robinson J.O., da Silva A.G., Seemann T., Howden B.P., Johnson P.D.R., Stinear T.P. Increasing tolerance of hospital Enterococcus faecium to handwash alcohols. // Science Translational Medicine. 2018. Vol. 10, № 452. eaar6115.
Basha S., Surendran N., Pichichero M. Immune responses in neonates. // Expert Rev Clin Immunol. 2014. Vol. 10, № 9. P. 1171–1184.
Читать дальше